NICE U-turn on Imbruvica®▼(ibrutinib) means patients with Waldenström’s …

from Google Alert at http://bit.ly/2yMQyXk on September 29, 2017 at 11:19PM


Jennifer Lee, Director of Health Economics, Market Access & Reimbursement (HEMAR) and Advocacy at Janssen UK, said “This decision is welcome …